i3S-Hovione Capital

The Institute for Research and Innovation in Health (i3S) is a multidisciplinary research Unit funded by FCT since Jan. 2015, focused in research, innovation and training, to address major societal challenges that drive research questions in Biomedical Sciences. For that, i3S brings together internationally recognized researchers with competences in basic, translational and clinical research, in a model that potentiates the full cycle from “bench to bedside”. 

i3S's vision is to become a major European player in health sciences and technologies by gaining critical mass, favouring the emergence of new scientific areas, fostering integrative PhD programs, encouraging stronger interaction with hospitals and companies, and promoting an entrepreneurial environment and outreach initiatives.

Hovione Capital is a privately held Asset Management company especializing in the Healthcare sector. As a venture capital investor, we especialize in identifying and investing in high-potential seed/early-stage investment opportunities that provide medical device, medical technology, diagnostic, chronic disease monitoring, IT-integration opportunities. The projects Hovione Capital is looking for benefit from patented differentiating technologies, which are directly scalable and address the global market. Leveraging on existing economies of scope, we are particularly interested in information rich m-health, medical device and medical technology projects, that address and provide measurable benefits to patients, caretakers, caregivers, as well as reimbursement and health care systems

The Institute for Research and Innovation in Health (i3S) is a multidisciplinary research Unit funded by FCT since Jan. 2015, focused in research, innovation and training, to address major societal challenges that drive research questions in Biomedical Sciences. For that, i3S brings together internationally recognized researchers with competences in basic, translational and clinical research, in a model that potentiates the full cycle from “bench to bedside”. 

i3S's vision is to become a major European player in health sciences and technologies by gaining critical mass, favouring the emergence of new scientific areas, fostering integrative PhD programs, encouraging stronger interaction with hospitals and companies, and promoting an entrepreneurial environment and outreach initiatives.

Hovione Capital is a privately held Asset Management company especializing in the Healthcare sector. As a venture capital investor, we especialize in identifying and investing in high-potential seed/early-stage investment opportunities that provide medical device, medical technology, diagnostic, chronic disease monitoring, IT-integration opportunities. The projects Hovione Capital is looking for benefit from patented differentiating technologies, which are directly scalable and address the global market. Leveraging on existing economies of scope, we are particularly interested in information rich m-health, medical device and medical technology projects, that address and provide measurable benefits to patients, caretakers, caregivers, as well as reimbursement and health care systems

Eventos

Lamentamos, não existem eventos futuros